(Q48612827)

13 February 2018

title

The narcoleptic borderland: a multimodal diagnostic approach including cerebrospinal fluid levels of hypocretin-1 (orexin A). (English)

1 reference

13 February 2018

0 references

0 references

6

1 reference

13 February 2018

Beth Ripley

object named as

Beth Ripley

8

0 references

Emmanuel Mignot

10

object named as

Emmanuel Mignot

1 reference

13 February 2018

Claudio Bassetti

1

1 reference

13 February 2018

Matthias Gugger

2

1 reference

13 February 2018

Matthias Bischof

3

1 reference

13 February 2018

Johannes Mathis

4

1 reference

13 February 2018

Christian Sturzenegger

5

1 reference

13 February 2018

Bogdan Radanov

7

1 reference

13 February 2018

Seiji Nishino

9

1 reference

13 February 2018

publication date

1 January 2003

1 reference

13 February 2018

number of pages

6

1 reference

inferred from page(s)

published in

Sleep Medicine

1 reference

13 February 2018

volume

4

1 reference

13 February 2018

issue

1

1 reference

13 February 2018

page(s)

7-12

1 reference

13 February 2018

https://api.crossref.org/works/10.1016%2FS1389-9457%2802%2900191-0

1 reference

7 January 2021

Idiopathic hypersomnia. A series of 42 patients

1 reference

https://api.crossref.org/works/10.1016%2FS1389-9457%2802%2900191-0

7 January 2021

The hypocretin/orexin ligand-receptor system: implications for sleep and sleep disorders.

1 reference

https://api.crossref.org/works/10.1016%2FS1389-9457%2802%2900191-0

7 January 2021

The sleep disorder canine narcolepsy is caused by a mutation in the hypocretin (orexin) receptor 2 gene

1 reference

https://api.crossref.org/works/10.1016%2FS1389-9457%2802%2900191-0

7 January 2021

Narcolepsy in orexin knockout mice: molecular genetics of sleep regulation

1 reference

https://api.crossref.org/works/10.1016%2FS1389-9457%2802%2900191-0

7 January 2021

A mutation in a case of early onset narcolepsy and a generalized absence of hypocretin peptides in human narcoleptic brains

1 reference

https://api.crossref.org/works/10.1016%2FS1389-9457%2802%2900191-0

7 January 2021

Aprepro-orexingene polymorphism is associated with narcolepsy: Table 1

1 reference

https://api.crossref.org/works/10.1016%2FS1389-9457%2802%2900191-0

7 January 2021

Hypocretin (orexin) deficiency in human narcolepsy.

1 reference

https://api.crossref.org/works/10.1016%2FS1389-9457%2802%2900191-0

7 January 2021

Low cerebrospinal fluid hypocretin (Orexin) and altered energy homeostasis in human narcolepsy.

1 reference

https://api.crossref.org/works/10.1016%2FS1389-9457%2802%2900191-0

7 January 2021

CSF hypocretin/orexin levels in narcolepsy and other neurological conditions.

1 reference

https://api.crossref.org/works/10.1016%2FS1389-9457%2802%2900191-0

7 January 2021

Reduced number of hypocretin neurons in human narcolepsy

1 reference

https://api.crossref.org/works/10.1016%2FS1389-9457%2802%2900191-0

7 January 2021

Increased body-mass index in patients with narcolepsy.

1 reference

https://api.crossref.org/works/10.1016%2FS1389-9457%2802%2900191-0

7 January 2021

The role of cerebrospinal fluid hypocretin measurement in the diagnosis of narcolepsy and other hypersomnias

1 reference

https://api.crossref.org/works/10.1016%2FS1389-9457%2802%2900191-0

7 January 2021

Epidemiology of narcolepsy.

1 reference

https://api.crossref.org/works/10.1016%2FS1389-9457%2802%2900191-0

7 January 2021

The clinical diagnosis of the narcoleptic syndrome.

1 reference

https://api.crossref.org/works/10.1016%2FS1389-9457%2802%2900191-0

7 January 2021

Sensitivity and specificity of the multiple sleep latency test (MSLT), the maintenance of wakefulness test and the epworth sleepiness scale: failure of the MSLT as a gold standard

1 reference

https://api.crossref.org/works/10.1016%2FS1389-9457%2802%2900191-0

7 January 2021

Diagnostic aspects of narcolepsy

1 reference

https://api.crossref.org/works/10.1016%2FS1389-9457%2802%2900191-0

7 January 2021

The clinical spectrum of narcolepsy and idiopathic hypersomnia

1 reference

https://api.crossref.org/works/10.1016%2FS1389-9457%2802%2900191-0

7 January 2021

Hypersomnia associated with mood disorders: a new perspective.

1 reference

https://api.crossref.org/works/10.1016%2FS1389-9457%2802%2900191-0

7 January 2021

Hypersomnia in bipolar depression: a comparison with narcolepsy using the multiple sleep latency test

1 reference

https://api.crossref.org/works/10.1016%2FS1389-9457%2802%2900191-0

7 January 2021

Dopaminergic role in stimulant-induced wakefulness.

1 reference

https://api.crossref.org/works/10.1016%2FS1389-9457%2802%2900191-0

7 January 2021

Brain dopamine and obesity

1 reference

https://api.crossref.org/works/10.1016%2FS1389-9457%2802%2900191-0

7 January 2021

Cellular and molecular mechanisms of drug dependence

1 reference

https://api.crossref.org/works/10.1016%2FS1389-9457%2802%2900191-0

7 January 2021

10.1016/S1389-9457(02)00191-0

Identifiers

DOI

1 reference

13 February 2018

1 reference

13 February 2018